ARMANDI, ANGELO
ARMANDI, ANGELO
SCIENZE MEDICHE
A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease
2023-01-01 Nuria Perez-Diaz-Del-Campo, Eleonora Dileo, Gabriele Castelnuovo, Aurora Nicolosi, Marta Guariglia, Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Elisabetta Bugianesi
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy
2021-01-01 Ribaldone, DG; Zurlo, C; Fagoonee, S; Rosso, C; Armandi, A; Caviglia, GP; Saracco, GM; Pellicano, R
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals
2022-01-01 Saponaro, Chiara; Sabatini, Silvia; Gaggini, Melania; Carli, Fabrizia; Rosso, Chiara; Positano, Vincenzo; Armandi, Angelo; Caviglia, Gian Paolo; Faletti, Riccardo; Bugianesi, Elisabetta; Gastaldelli, Amalia
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology
2020-01-01 Caviglia, Gian Paolo; Ciruolo, Michela; Abate, Maria Lorena; Carucci, Patrizia; Rolle, Emanuela; Rosso, Chiara; Olivero, Antonella; Troshina, Giulia; Risso, Alessandra; Nicolosi, Aurora; Ribaldone, Davide Giuseppe; Armandi, Angelo; Tandoi, Francesco; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Ciancio, Alessia; Gaia, Silvia
Analytical and clinical comparison between two different chemiluminescent enzyme immunoassays for the measurement of C-peptide in serum
2021-01-01 Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Davide Giuseppe Ribaldone, Rinaldo Pellicano, Elisabetta Bugianesi
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease?
2021-01-01 Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, Davide Giuseppe Ribaldone, Elisabetta Bugianesi
Beyond the paradigm of weight loss in non‐alcoholic fatty liver disease: From pathophysiology to novel dietary approaches
2021-01-01 Armandi A.; Schattenberg J.M.
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
2021-01-01 Caviglia G.P.; Armandi A.; Rosso C.; Gaia S.; Aneli S.; Rolle E.; Abate M.L.; Olivero A.; Nicolosi A.; Guariglia M.; Ribaldone D.G.; Carucci P.; Saracco G.M.; Bugianesi E.
Can Periodontitis Affect the Health and Disease of the Digestive System? A Comprehensive Review of Epidemiological Evidence and Biological Mechanisms
2021-01-01 Baima G.; Ribaldone D.G.; Muwalla M.; Romano F.; Citterio F.; Armandi A.; Aimetti M.
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
2022-01-01 Younes, Ramy; Govaere, Olivier; Petta, Salvatore; Miele, Luca; Tiniakos, Dina; Burt, Alastair; David, Ezio; Vecchio, Fabio Maria; Maggioni, Marco; Cabibi, Daniela; McLeod, Duncan; Pareja, Maria Jesus; Fracanzani, Anna Ludovica; Aller, Rocio; Rosso, Chiara; Ampuero, Javier; Gallego-Durán, Rocío; Armandi, Angelo; Caviglia, Gian Paolo; Zaki, Marco Y W; Liguori, Antonio; Francione, Paolo; Pennisi, Grazia; Grieco, Antonio; Birolo, Giovanni; Fariselli, Piero; Eslam, Mohammed; Valenti, Luca; George, Jacob; Romero-Gómez, Manuel; Anstee, Quentin Mark; Bugianesi, Elisabetta
Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension Following Hepatitis C Virus Eradication in Cirrhotic Individuals
2022-01-01 Angelo Armandi, Chiara Rosso, Giulia Troshina, Nuria Perez Diaz Del Campo, Chiara Marinoni, Aurora Nicolosi, Gian Paolo Caviglia, Giorgio Maria Saracco, Elisabetta Bugianesi, Alessia Ciancio
Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives
2022-01-01 Meineri G.; Martello E.; Radice E.; Bruni N.; Saettone V.; Atuahene D.; Armandi A.; Testa G.; Ribaldone D.G.
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification
2022-01-01 Olivero A.; Rosso C.; Ciancio A.; Abate M.L.; Nicolosi A.; Troshina G.; Armandi A.; Ribaldone D.G.; Saracco G.M.; Bugianesi E.; Rizzetto M.; Caviglia G.P.
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy
2018-01-01 Shahini, Endrit; Iannone, Andrea; Romagno, Domenico; Armandi, Angelo; Carparelli, Sonia; Principi, Mariabeatrice; Viggiani, Maria Teresa; Ierardi, Enzo; Di Leo, Alfredo; Barone, Michele
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report
2020-01-01 Caviglia, Gian Paolo; Tucci, Alessandra; Pellicano, Rinaldo; Fagoonee, Sharmila; Rosso, Chiara; Abate, Maria Lorena; Olivero, Antonella; Armandi, Angelo; Vanni, Ester; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Astegiano, Marco; Ribaldone, Davide Giuseppe
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
2023-01-01 Armandi, Angelo; Rosso, Chiara; Younes, Ramy; Leeming, Diana Julie; Karsdal, Morten A; Caviglia, Gian Paolo; Pérez-Diaz-Del-Campo, Nuria; D'Amato, Daphne; Abdulle, Amina; Nicolosi, Aurora; Castelnuovo, Gabriele; Saracco, Giorgio Maria; Ribaldone, Davide Giuseppe; Bugianesi, Elisabetta
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
2022-01-01 Armandi A.; Rosso C.; Nicolosi A.; Caviglia G.P.; Abate M.L.; Olivero A.; D'amato D.; Vernero M.; Gaggini M.; Saracco G.M.; Ribaldone D.G.; Leeming D.J.; Gastaldelli A.; Bugianesi E.
Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis
2022-01-01 Labenz C, Toenges G, Zheng M, Ding D, Myers RP, Galle PR, Armandi A, Ampuero J, Romero Gomez M, Bugianesi E, Anstee QM, Schattenberg JM
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis
2021-01-01 Mozes F.E.; Lee J.A.; Selvaraj E.A.; Jayaswal A.N.A.; Trauner M.; Boursier J.; Fournier C.; Staufer K.; Stauber R.E.; Bugianesi E.; Younes R.; Gaia S.; Lupsor-Platon M.; Petta S.; Shima T.; Okanoue T.; Mahadeva S.; Chan W.-K.; Eddowes P.J.; Newsome P.N.; Wong V.W.-S.; de Ledinghen V.; Fan J.; Shen F.; Cobbold J.F.; Sumida Y.; Okajima A.; Schattenberg J.M.; Labenz C.; Kim W.; Lee M.S.; Wiegand J.; Karlas T.; Yilmaz Y.; Aithal G.P.; Palaniyappan N.; Cassinotto C.; Aggarwal S.; Garg H.; Ooi G.J.; Nakajima A.; Yoneda M.; Ziol M.; Barget N.; Geier A.; Tuthill T.; Brosnan M.J.; Anstee Q.M.; Neubauer S.; Harrison S.A.; Bossuyt P.M.; Pavlides M.; Anstee Q.; Daly A.; Johnson K.; Govaere O.; Cockell S.; Tiniakos D.; Bedossa P.; Oakley F.; Cordell H.; Day C.; Wonders K.; Bossuyt P.; Zafarmand H.; Vali Y.; Lee J.; Ratziu V.; Clement K.; Pais R.; Schuppan D.; Schattenberg J.; Schuppan D.; Schattenberg J.; Vidal-Puig T.; Vacca M.; Rodrigues-Cuenca S.; Allison M.; Kamzolas I.; Petsalaki E.; Oresic M.; Hyotylainen T.; McGlinchey A.; Mato J.M.; Millet O.; Dufour J.-F.; Berzigotti A.; Pavlides M.; Harrison S.; Neubauer S.; Cobbold J.; Mozes F.; Akhtar S.; Banerjee R.; Kelly M.; Shumbayawonda E.; Dennis A.; Erpicum C.; Graham M.; Romero-Gomez M.; Gomez-Gonzalez E.; Ampuero J.; Castell J.; Gallego-Duran R.; Fernandez I.; Montero-Vallejo R.; Karsdal M.; Erhardtsen E.; Rasmussen D.; Leeming D.J.; Fisker M.J.; Sinisi A.; Musa K.; Betsou F.; Sandt E.; Tonini M.; Bugianesi E.; Rosso C.; Armandi A.; Marra F.; Gastaldelli A.; Svegliati G.; Boursier J.; Francque S.; Vonghia L.; Ekstedt M.; Kechagias S.; Yki-Jarvinen H.; Porthan K.; van Mil S.; Papatheodoridis G.; Cortez-Pinto H.; Valenti L.; Petta S.; Miele L.; Geier A.; Trautwein C.; Aithal G.; Hockings P.; Newsome P.; Wenn D.; Rodrigues C.M.P.; Chaumat P.; Hanf R.; Trylesinski A.; Ortiz P.; Duffin K.; Brosnan J.; Tuthill T.; McLeod E.; Ertle J.; Younes R.; Ostroff R.; Alexander L.; Kjaer M.S.; Mikkelsen L.F.; Balp M.-M.; Brass C.; Jennings L.; Martic M.; Loeffler J.; Hanauer G.; Shankar S.; Fournier C.; Pepin K.; Ehman R.; Myers J.; Ho G.; Torstenson R.; Myers R.; Doward L.
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message
2019-01-01 Armandi, Angelo; Bonetto, Silvia; Pellicano, Rinaldo; Caviglia, Gian Paolo; Astegiano, Marco; Saracco, Giorgio M.; Ribaldone, Davide G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease | 2023 | Nuria Perez-Diaz-Del-Campo, Eleonora Dileo, Gabriele Castelnuovo, Aurora Nicolosi, Marta Guariglia, Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Elisabetta Bugianesi | |
| A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy | 2021 | Ribaldone, DG; Zurlo, C; Fagoonee, S; Rosso, C; Armandi, A; Caviglia, GP; Saracco, GM; Pellicano, R | |
| Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals | 2022 | Saponaro, Chiara; Sabatini, Silvia; Gaggini, Melania; Carli, Fabrizia; Rosso, Chiara; Positano, Vincenzo; Armandi, Angelo; Caviglia, Gian Paolo; Faletti, Riccardo; Bugianesi, Elisabetta; Gastaldelli, Amalia | |
| Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology | 2020 | Caviglia, Gian Paolo; Ciruolo, Michela; Abate, Maria Lorena; Carucci, Patrizia; Rolle, Emanuela; Rosso, Chiara; Olivero, Antonella; Troshina, Giulia; Risso, Alessandra; Nicolosi, Aurora; Ribaldone, Davide Giuseppe; Armandi, Angelo; Tandoi, Francesco; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Ciancio, Alessia; Gaia, Silvia | |
| Analytical and clinical comparison between two different chemiluminescent enzyme immunoassays for the measurement of C-peptide in serum | 2021 | Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Davide Giuseppe Ribaldone, Rinaldo Pellicano, Elisabetta Bugianesi | |
| Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease? | 2021 | Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, Davide Giuseppe Ribaldone, Elisabetta Bugianesi | |
| Beyond the paradigm of weight loss in non‐alcoholic fatty liver disease: From pathophysiology to novel dietary approaches | 2021 | Armandi A.; Schattenberg J.M. | |
| Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease | 2021 | Caviglia G.P.; Armandi A.; Rosso C.; Gaia S.; Aneli S.; Rolle E.; Abate M.L.; Olivero A.; Nicolosi A.; Guariglia M.; Ribaldone D.G.; Carucci P.; Saracco G.M.; Bugianesi E. | |
| Can Periodontitis Affect the Health and Disease of the Digestive System? A Comprehensive Review of Epidemiological Evidence and Biological Mechanisms | 2021 | Baima G.; Ribaldone D.G.; Muwalla M.; Romano F.; Citterio F.; Armandi A.; Aimetti M. | |
| Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? | 2022 | Younes, Ramy; Govaere, Olivier; Petta, Salvatore; Miele, Luca; Tiniakos, Dina; Burt, Alastair; David, Ezio; Vecchio, Fabio Maria; Maggioni, Marco; Cabibi, Daniela; McLeod, Duncan; Pareja, Maria Jesus; Fracanzani, Anna Ludovica; Aller, Rocio; Rosso, Chiara; Ampuero, Javier; Gallego-Durán, Rocío; Armandi, Angelo; Caviglia, Gian Paolo; Zaki, Marco Y W; Liguori, Antonio; Francione, Paolo; Pennisi, Grazia; Grieco, Antonio; Birolo, Giovanni; Fariselli, Piero; Eslam, Mohammed; Valenti, Luca; George, Jacob; Romero-Gómez, Manuel; Anstee, Quentin Mark; Bugianesi, Elisabetta | |
| Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension Following Hepatitis C Virus Eradication in Cirrhotic Individuals | 2022 | Angelo Armandi, Chiara Rosso, Giulia Troshina, Nuria Perez Diaz Del Campo, Chiara Marinoni, Aurora Nicolosi, Gian Paolo Caviglia, Giorgio Maria Saracco, Elisabetta Bugianesi, Alessia Ciancio | |
| Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives | 2022 | Meineri G.; Martello E.; Radice E.; Bruni N.; Saettone V.; Atuahene D.; Armandi A.; Testa G.; Ribaldone D.G. | |
| Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification | 2022 | Olivero A.; Rosso C.; Ciancio A.; Abate M.L.; Nicolosi A.; Troshina G.; Armandi A.; Ribaldone D.G.; Saracco G.M.; Bugianesi E.; Rizzetto M.; Caviglia G.P. | |
| Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy | 2018 | Shahini, Endrit; Iannone, Andrea; Romagno, Domenico; Armandi, Angelo; Carparelli, Sonia; Principi, Mariabeatrice; Viggiani, Maria Teresa; Ierardi, Enzo; Di Leo, Alfredo; Barone, Michele | |
| Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report | 2020 | Caviglia, Gian Paolo; Tucci, Alessandra; Pellicano, Rinaldo; Fagoonee, Sharmila; Rosso, Chiara; Abate, Maria Lorena; Olivero, Antonella; Armandi, Angelo; Vanni, Ester; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Astegiano, Marco; Ribaldone, Davide Giuseppe | |
| Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease | 2023 | Armandi, Angelo; Rosso, Chiara; Younes, Ramy; Leeming, Diana Julie; Karsdal, Morten A; Caviglia, Gian Paolo; Pérez-Diaz-Del-Campo, Nuria; D'Amato, Daphne; Abdulle, Amina; Nicolosi, Aurora; Castelnuovo, Gabriele; Saracco, Giorgio Maria; Ribaldone, Davide Giuseppe; Bugianesi, Elisabetta | |
| Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease | 2022 | Armandi A.; Rosso C.; Nicolosi A.; Caviglia G.P.; Abate M.L.; Olivero A.; D'amato D.; Vernero M.; Gaggini M.; Saracco G.M.; Ribaldone D.G.; Leeming D.J.; Gastaldelli A.; Bugianesi E. | |
| Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis | 2022 | Labenz C, Toenges G, Zheng M, Ding D, Myers RP, Galle PR, Armandi A, Ampuero J, Romero Gomez M, Bugianesi E, Anstee QM, Schattenberg JM | |
| Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis | 2021 | Mozes F.E.; Lee J.A.; Selvaraj E.A.; Jayaswal A.N.A.; Trauner M.; Boursier J.; Fournier C.; Staufer K.; Stauber R.E.; Bugianesi E.; Younes R.; Gaia S.; Lupsor-Platon M.; Petta S.; Shima T.; Okanoue T.; Mahadeva S.; Chan W.-K.; Eddowes P.J.; Newsome P.N.; Wong V.W.-S.; de Ledinghen V.; Fan J.; Shen F.; Cobbold J.F.; Sumida Y.; Okajima A.; Schattenberg J.M.; Labenz C.; Kim W.; Lee M.S.; Wiegand J.; Karlas T.; Yilmaz Y.; Aithal G.P.; Palaniyappan N.; Cassinotto C.; Aggarwal S.; Garg H.; Ooi G.J.; Nakajima A.; Yoneda M.; Ziol M.; Barget N.; Geier A.; Tuthill T.; Brosnan M.J.; Anstee Q.M.; Neubauer S.; Harrison S.A.; Bossuyt P.M.; Pavlides M.; Anstee Q.; Daly A.; Johnson K.; Govaere O.; Cockell S.; Tiniakos D.; Bedossa P.; Oakley F.; Cordell H.; Day C.; Wonders K.; Bossuyt P.; Zafarmand H.; Vali Y.; Lee J.; Ratziu V.; Clement K.; Pais R.; Schuppan D.; Schattenberg J.; Schuppan D.; Schattenberg J.; Vidal-Puig T.; Vacca M.; Rodrigues-Cuenca S.; Allison M.; Kamzolas I.; Petsalaki E.; Oresic M.; Hyotylainen T.; McGlinchey A.; Mato J.M.; Millet O.; Dufour J.-F.; Berzigotti A.; Pavlides M.; Harrison S.; Neubauer S.; Cobbold J.; Mozes F.; Akhtar S.; Banerjee R.; Kelly M.; Shumbayawonda E.; Dennis A.; Erpicum C.; Graham M.; Romero-Gomez M.; Gomez-Gonzalez E.; Ampuero J.; Castell J.; Gallego-Duran R.; Fernandez I.; Montero-Vallejo R.; Karsdal M.; Erhardtsen E.; Rasmussen D.; Leeming D.J.; Fisker M.J.; Sinisi A.; Musa K.; Betsou F.; Sandt E.; Tonini M.; Bugianesi E.; Rosso C.; Armandi A.; Marra F.; Gastaldelli A.; Svegliati G.; Boursier J.; Francque S.; Vonghia L.; Ekstedt M.; Kechagias S.; Yki-Jarvinen H.; Porthan K.; van Mil S.; Papatheodoridis G.; Cortez-Pinto H.; Valenti L.; Petta S.; Miele L.; Geier A.; Trautwein C.; Aithal G.; Hockings P.; Newsome P.; Wenn D.; Rodrigues C.M.P.; Chaumat P.; Hanf R.; Trylesinski A.; Ortiz P.; Duffin K.; Brosnan J.; Tuthill T.; McLeod E.; Ertle J.; Younes R.; Ostroff R.; Alexander L.; Kjaer M.S.; Mikkelsen L.F.; Balp M.-M.; Brass C.; Jennings L.; Martic M.; Loeffler J.; Hanauer G.; Shankar S.; Fournier C.; Pepin K.; Ehman R.; Myers J.; Ho G.; Torstenson R.; Myers R.; Doward L. | |
| Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message | 2019 | Armandi, Angelo; Bonetto, Silvia; Pellicano, Rinaldo; Caviglia, Gian Paolo; Astegiano, Marco; Saracco, Giorgio M.; Ribaldone, Davide G. |